301 related articles for article (PubMed ID: 19423014)
1. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.
Evens N; Muccioli GG; Houbrechts N; Lambert DM; Verbruggen AM; Van Laere K; Bormans GM
Nucl Med Biol; 2009 May; 36(4):455-65. PubMed ID: 19423014
[TBL] [Abstract][Full Text] [Related]
2. Labelling and biological evaluation of [(11)C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor.
Evens N; Bosier B; Lavey BJ; Kozlowski JA; Vermaelen P; Baudemprez L; Busson R; Lambert DM; Van Laere K; Verbruggen AM; Bormans GM
Nucl Med Biol; 2008 Oct; 35(7):793-800. PubMed ID: 18848664
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of novel PET tracers for imaging cannabinoid receptor type 2 in brain.
Slavik R; Bieri D; Cermak S; Müller A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
Chimia (Aarau); 2014; 68(4):208-10. PubMed ID: 24983598
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.
Turkman N; Shavrin A; Paolillo V; Yeh HH; Flores L; Soghomonian S; Rabinovich B; Volgin A; Gelovani J; Alauddin M
Nucl Med Biol; 2012 May; 39(4):593-600. PubMed ID: 22226022
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor.
Slavik R; Herde AM; Bieri D; Weber M; Schibli R; Krämer SD; Ametamey SM; Mu L
Eur J Med Chem; 2015 Mar; 92():554-64. PubMed ID: 25599952
[TBL] [Abstract][Full Text] [Related]
7. Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18.
Hamill TG; Sato N; Jitsuoka M; Tokita S; Sanabria S; Eng W; Ryan C; Krause S; Takenaga N; Patel S; Zeng Z; Williams D; Sur C; Hargreaves R; Burns HD
Synapse; 2009 Dec; 63(12):1122-32. PubMed ID: 19670309
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEP.
Suter TM; Chesterfield AK; Bao C; Schaus JM; Krushinski JH; Statnick MA; Felder CC
Eur J Pharmacol; 2010 Dec; 649(1-3):44-50. PubMed ID: 20851117
[TBL] [Abstract][Full Text] [Related]
10. Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
Stern E; Muccioli GG; Millet R; Goossens JF; Farce A; Chavatte P; Poupaert JH; Lambert DM; Depreux P; Hénichart JP
J Med Chem; 2006 Jan; 49(1):70-9. PubMed ID: 16392793
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 18F-FA-4 and 11C-pipzA-4 as radioligands for the in vivo evaluation of the high-affinity choline uptake system.
Gilissen C; de Groot TJ; Bronfman F; van Leuven F; Verbruggen AM; Bormans GM
J Nucl Med; 2003 Feb; 44(2):269-75. PubMed ID: 12571220
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents.
Serdons K; Van Laere K; Janssen P; Kung HF; Bormans G; Verbruggen A
J Med Chem; 2009 Nov; 52(22):7090-102. PubMed ID: 19877643
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
Willis PG; Pavlova OA; Chefer SI; Vaupel DB; Mukhin AG; Horti AG
J Med Chem; 2005 Sep; 48(18):5813-22. PubMed ID: 16134948
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new carbon-11 labeled benzoxazole derivatives for PET imaging of 5-HT(3) receptor.
Gao M; Wang M; Hutchins GD; Zheng QH
Eur J Med Chem; 2008 Jul; 43(7):1570-4. PubMed ID: 18045745
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors.
Cappelli A; Matarrese M; Moresco RM; Valenti S; Anzini M; Vomero S; Turolla EA; Belloli S; Simonelli P; Filannino MA; Lecchi M; Fazio F
Bioorg Med Chem; 2006 Jun; 14(12):4055-66. PubMed ID: 16495062
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.
Hortala L; Arnaud J; Roux P; Oustric D; Boulu L; Oury-Donat F; Avenet P; Rooney T; Alagille D; Barret O; Tamagnan G; Barth F
Bioorg Med Chem Lett; 2014 Jan; 24(1):283-7. PubMed ID: 24291040
[TBL] [Abstract][Full Text] [Related]
18. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
[TBL] [Abstract][Full Text] [Related]
19. A ¹⁸F-labeled fluorobutyl-substituted spirocyclic piperidine derivative as a selective radioligand for PET Imaging of sigma₁ receptors.
Maisonial A; Grosse Maestrup E; Fischer S; Hiller A; Scheunemann M; Wiese C; Schepmann D; Steinbach J; Deuther-Conrad W; Wünsch B; Brust P
ChemMedChem; 2011 Aug; 6(8):1401-10. PubMed ID: 21618432
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer.
Evens N; Vandeputte C; Coolen C; Janssen P; Sciot R; Baekelandt V; Verbruggen AM; Debyser Z; Van Laere K; Bormans GM
Nucl Med Biol; 2012 Apr; 39(3):389-99. PubMed ID: 22154685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
